{"id":3738,"date":"2026-05-23T14:33:25","date_gmt":"2026-05-23T19:33:25","guid":{"rendered":"https:\/\/www.drdanamd.com\/?post_type=blog&p=3738"},"modified":"2026-05-23T14:33:26","modified_gmt":"2026-05-23T19:33:26","slug":"are-coolsculpting-and-cooltone-good-options-after-glp-1-weight-loss","status":"publish","type":"blog","link":"https:\/\/www.drdanamd.com\/blog\/are-coolsculpting-and-cooltone-good-options-after-glp-1-weight-loss\/","title":{"rendered":"Are CoolSculpting and CoolTone Good Options After GLP-1 Weight Loss?"},"content":{"rendered":"

GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound have genuinely transformed what’s possible for patients struggling with weight. The results can be remarkable. But the body that emerges on the other side of significant weight loss isn’t always the one patients imagined \u2014 and that’s where my practice comes in.<\/p>\n

Let me walk you through honestly what CoolSculpting and CoolTone can and can’t do for patients who have lost weight on GLP-1 medications, and where they fit in the broader picture of post-weight-loss body contouring.<\/p>\n

What GLP-1 Weight Loss Does to the Body<\/h3>\n

GLP-1 medications<\/a> work by reducing appetite and slowing gastric emptying, leading to a caloric deficit that produces meaningful weight loss over months. The results, for many patients, are genuinely impressive \u2014 15\u201325% body weight reduction is not uncommon with the newer generation of these medications.<\/p>\n

But significant weight loss \u2014 whether from GLP-1 medications, bariatric surgery, or diet and exercise \u2014 creates a specific set of body changes that are worth understanding:<\/p>\n

Fat loss:<\/strong> The primary goal, and it happens. Fat deposits throughout the body shrink as the body draws on stored energy.<\/p>\n

Muscle loss:<\/strong> This is the part many patients don’t anticipate. GLP-1 medications don’t selectively target fat \u2014 they create a caloric deficit, and the body will break down muscle tissue alongside fat if protein intake and resistance training aren’t carefully managed. Studies suggest that 25\u201340% of weight lost on GLP-1 medications may be muscle mass. For patients who weren’t already very active or who lost weight rapidly, this can be significant.<\/p>\n

Skin laxity:<\/strong> As fat volume decreases, the skin that was stretched over it doesn’t always follow. The speed of weight loss and the degree of stretch both affect how well skin contracts \u2014 and for many patients, particularly those over 40 or those who lost a large amount of weight, some degree of loose skin is the result.<\/p>\n

Redistributed fat pockets:<\/strong> Even after significant overall fat reduction, stubborn localized fat deposits often remain \u2014 areas where the body holds onto fat preferentially regardless of overall weight. These are the spots that were resistant before GLP-1 medications, and they often remain resistant after.<\/p>\n

Where CoolSculpting Fits In<\/h3>\n

CoolSculpting is well-suited for GLP-1 patients who have:<\/p>\n